Vyant Bio Inc 's ability to collect accounts receivable sequentially worsen to 1.5, pointing to a challenging and on top of that deteriorating business climate for the Medical Laboratories industry. Vyant Bio Inc 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 243 days, from 175 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 659 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 0 to 4171.

What is Receivable Turnover Ratio?
What is Vyant Bio Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VYNT Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	-25.58 %	-67.87 %	-61.62 %	-36.69 %	-50.11 %
Y / Y Revenue Change	-87.22 %	-89.91 %	-91.53 %	36.49 %	-72.54 %
Receivable Turnover Ratio (TTM)	1.5	2.08	3.46	4.74	4.24
VYNT's Total Ranking	# 4171	# 0	# 0	# 4623	# 4159
Accounts Receivable average collection period days	243	176	105	77	86
Seq. Receivable Change	-15.67 %	-20.87 %	-17.26 %	34.79 %	-63.59 %
Seq. Revenue Change	-69.74 %	-7.88 %	-45.54 %	-15.83 %	-76.1 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 43
Healthcare Sector	# 660
Overall Market	# 4171

Receivable Turnover Ratio Statistics
High	Average	Low
5.09	2.43	-4.04
(Jun 30 2021)		(Sep 30 2022)

VYNT Company Profile • Back to VYNT Efficiency Comparisons • Compare VYNT Receivables Turnover Ratio to its Competitors

Financial Statements
Vyant Bio Inc 's Accounts Receivable	$ 0 Millions	Visit VYNT's Balance sheet
Vyant Bio Inc 's Sales TTM	$ 1 Millions	Visit VYNT's Income Statement
Sources of VYNT's Revenues		Visit VYNT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VYNT's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VYNT's Growth Rates	VYNT's Roa	VYNT's Inventory Turnover Ratio	VYNT's Dividend Comparisons
VYNT's Profitability Ratios	VYNT's Roi	VYNT's Asset Turnover Ratio	VYNT's Dividend Growth
VYNT's Valuation Ratios	VYNT's Roe	VYNT's Financial Strength Ratios	VYNT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Societal Cdmo Inc	5.66	$ 90.214 Millions	$ 15.926 Millions
Deciphera Pharmaceuticals Inc	5.66	$ 134.036 Millions	$ 23.677 Millions
Cryoport inc	5.65	$ 237.277 Millions	$ 42.004 Millions
Butterfly Network Inc	5.64	$ 73.714 Millions	$ 13.064 Millions
Adm Tronics Unlimited Inc	5.63	$ 3.929 Millions	$ 0.698 Millions
Redhill Biopharma Ltd	5.61	$ 61.800 Millions	$ 11.009 Millions
Cryo cell International Inc	5.59	$ 30.337 Millions	$ 5.423 Millions
Medtronic Plc	5.59	$ 30,772.000 Millions	$ 5,509.000 Millions
Akebia Therapeutics Inc	5.58	$ 292.484 Millions	$ 52.457 Millions
Rhythm Pharmaceuticals Inc	5.57	$ 16.884 Millions	$ 3.030 Millions
Neuropace Inc	5.54	$ 45.520 Millions	$ 8.223 Millions
Aurinia Pharmaceuticals Inc	5.53	$ 134.030 Millions	$ 24.257 Millions
Titan Pharmaceuticals Inc	5.51	$ 0.557 Millions	$ 0.101 Millions
Fulgent Genetics Inc	5.50	$ 618.968 Millions	$ 112.618 Millions
Iradimed Corporation	5.49	$ 53.303 Millions	$ 9.705 Millions
Genedx Holdings Corp	5.46	$ 234.694 Millions	$ 42.971 Millions
Rigel Pharmaceuticals Inc	5.45	$ 120.242 Millions	$ 22.071 Millions
Interpace Biosciences Inc	5.42	$ 31.838 Millions	$ 5.878 Millions
Horizon Therapeutics Public Limited Company	5.42	$ 3,629.044 Millions	$ 670.137 Millions
Incyte Corporation	5.41	$ 3,394.635 Millions	$ 627.095 Millions
Tenon Medical Inc	5.41	$ 0.691 Millions	$ 0.128 Millions
Eargo Inc	5.41	$ 37.248 Millions	$ 6.889 Millions
Conmed Corporation	5.40	$ 1,045.472 Millions	$ 193.500 Millions
Twist Bioscience Corporation	5.37	$ 215.790 Millions	$ 40.201 Millions
Charles River Laboratories International inc	5.36	$ 3,976.060 Millions	$ 742.153 Millions
Cytomx Therapeutics Inc	5.35	$ 53.163 Millions	$ 9.932 Millions
Bausch and Lomb Corp	5.34	$ 3,768.000 Millions	$ 705.000 Millions
Zimmer Biomet Holdings Inc	5.34	$ 6,939.900 Millions	$ 1,299.075 Millions
Pacific Biosciences Of California Inc	5.32	$ 128.304 Millions	$ 24.113 Millions
Docgo Inc	5.32	$ 440.516 Millions	$ 82.854 Millions

Date modified: 2026-09-08T15:10:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.